Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Nephropathy”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Not applicableUnknownNCT03547414
What this trial is testing

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

Who this might be right for
Acute Kidney InjurySeptic Shock
Centre Hospitalier Universitaire, Amiens 110
Early research (Phase 1)Study completedNCT00442871
What this trial is testing

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 29
Early research (Phase 1)Looking for participantsNCT07001436
What this trial is testing

A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects

Who this might be right for
Renal Insufficiency
Henan Genuine Biotech Co., Ltd. 40
Early research (Phase 1)Study completedNCT02320045
What this trial is testing

Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

Who this might be right for
Renal Insufficiency
Intarcia Therapeutics 38
Testing effectiveness (Phase 2)Study completedNCT01345656
What this trial is testing

BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

Who this might be right for
Heart Failure
Bayer 457
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Early research (Phase 1)Study completedNCT04142970
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Who this might be right for
Chronic Renal Impairment
Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Post-approval studies (Phase 4)Study completedNCT00369382
What this trial is testing

Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

Who this might be right for
Graft RejectionKidney Failure
Wyeth is now a wholly owned subsidiary of Pfizer 121
Testing effectiveness (Phase 2)Study completedNCT00004157
What this trial is testing

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Who this might be right for
Breast CancerGestational Trophoblastic TumorKidney Cancer+5 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Ended earlyNCT02679131
What this trial is testing

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Who this might be right for
Relapsed/Refractory Solid Tumors/Hematological Malignancies
Acrotech Biopharma Inc. 18
Early research (Phase 1)Study completedNCT00887627
What this trial is testing

Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function

Who this might be right for
Kidney DiseasesHyponatremia
Cumberland Pharmaceuticals 25
Testing effectiveness (Phase 2)Looking for participantsNCT03301038
What this trial is testing

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

Who this might be right for
Idiopathic Infantile Hypercalcaemia - Severe FormGenetic DiseaseHypercalcemia, Idiopathic, of Infancy+3 more
Children's Hospital of Philadelphia 60
Early research (Phase 1)Study completedNCT03289208
What this trial is testing

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

Who this might be right for
Renal ImpairmentHealthy
Tanabe Pharma Corporation 30
Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Early research (Phase 1)Study completedNCT03913000
What this trial is testing

Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

Who this might be right for
Renal Impairment
Idorsia Pharmaceuticals Ltd. 32
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Load More Results